Is Routine Nodal Dissection in Early Epithelial Ovarian Cancers Required?
Tóm tắt
The staging of ovarian cancer is unique because it is done surgically, wherein, along with hysterectomy and bilateral oophorectomy, pelvic and para-aortic nodes are routinely removed to find evidence of metastatic disease, which is not detected clinically. With advances in imaging modalities, it is now possible to predict, with reasonable accuracy, whether a regional lymph node is metastatic or not. Hence, in this study we compared the nodal staging in early ovarian cancers (FIGO I) as determined by CT scan (clinical nodal staging) with that of the nodal staging after a staging laparotomy (pathological nodal staging), to determine whether routine lymphadenectomy is justified in all patients with early epithelial ovarian cancer. Apparently early ovarian epithelial tumors were evaluated with contrast-enhanced computed tomography. Patients (n = 39) in whom the ovarian neoplasm appeared malignant and with pelvic and para-aortic nodes less than 10 mm in short-axis diameter and normal morphology were enrolled in the study. All women were subjected to a laparotomy and frozen section of the ovarian mass, followed by a routine staging laparotomy with pelvic and para-aortic nodal dissection, if the frozen section was reported as a malignant ovarian neoplasm. Clinical and pathological nodal staging was compared statistically. Pathological T stage, pathological subtype, grade, and CA-125 levels were also studied to determine whether these variables had an impact on the pathological nodal staging. The difference between clinical nodal staging (as determined by CT scan) and pathological nodal staging is insignificant (p 0.07). Factors, such as pathological T staging, pathological subtype, grade, and CA-125 levels, do not have a significant correlation with pathological nodal staging. Clinical staging of regional nodes, as determined by CT scan, correlates well with the pathological nodal staging in early epithelial ovarian cancer (FIGO I), and hence, a routine lymphadenectomy may not be warranted in all patients.
Tài liệu tham khảo
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2018;68:394–424. https://doi.org/10.3322/caac.21492.
[Internet]. Gco.iarc.fr. 2020 [cited 10 June 2020]. https://gco.iarc.fr/today/data/factsheets/populations/356-india-fact-sheets.pdf.
Sevin BU. Intraoperative staging in ovarian cancer. Baillieres Clin Obstet Gynaecol. 1989;3(1):13–21. https://doi.org/10.1016/s0950-3552(89)80037-9.
Widschwendter P, Blersch A, Friedl T, Janni W, Kloth C, de Gregorio A, et al. CT scan in the prediction of lymph node involvement in ovarian cancer—a retrospective analysis of a tertiary gyneco-oncological unit. Geburtshilfe Frauenheilkd. 2020;80(05):518–25.
Morice P, Joulie F, Camatte S, Atallah D, Rouzier R, Pautier P, Pomel C, Lhomme C, Duvillard P, Castaigne D. Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. J Am Coll Surg. 2003;197(2):198–205.
Benedetti-Panici P, Greggi S, Maneschi F, Scambia G, Amoroso M, Rabitti C, Mancuso S. Anatomical and pathological study of retroperitoneal nodes in epithelial ovarian cancer. Gynecol Oncol. 1993;51(2):150–4.
Petru E, Lahousen M, Tamussino K, Pickel H, Stranzl H, Stettner H, Winter R. Lymphadenectomy in stage I ovarian cancer. Am J Obstet Gynecol. 1994;170(2):656–62.
Harter P, Gnauert K, Hils R, Lehmann TG, Fisseler- Eckhoff A, Traut A, du Bois A. Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer. Int J Gynecol Cancer Off J Int Gynecol Cancer Soc. 2007;17(6):1238–44.
Burghardt E, Girardi F, Lahousen M, Tamussino K, Stettner H. Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer. Gynecol Oncol. 1991;40(2):103–6.
Jeong Y, Outwater E, Kang H. Imaging evaluation of ovarian masses. RadioGraphics. 2000;20(5):1445–70.
Sahdev A. CT in ovarian cancer staging: how to review and report with emphasis on abdominal and pelvic disease for surgical planning. Cancer Imaging. 2016;16(1):1–9.
Maggioni A, Benedetti Panici P, Dell’Anna T, Landoni F, Lissoni A, Pellegrino A, et al. Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer. 2006;95(6):699–704.
Gong Y, Wang Q, Dong L, Jia Y, Hua C, Mi F, et al. Different imaging techniques for the detection of pelvic lymph nodes metastasis from gynecological malignancies: a systematic review and meta-analysis. Oncotarget. 2017;8:14107.
Scheidler J. Radiological evaluation of lymph node metastases in patients with cervical cancer. JAMA. 1997;278(13):1096.
Mikami M. Role of lymphadenectomy for ovarian cancer. J Gynecol Oncol. 2014;25(4):279.
Chan J, Munro E, Cheung M, Husain A, Teng N, Berek J, et al. Association of lymphadenectomy and survival in stage I ovarian cancer patients. Obstet Gynecol. 2007;109(1):12–9.
Kleppe M, Wang T, Van Gorp T, Slangen BF, Kruse AJ, Kruitwagen RF. Lymph node metastasis in stages I and II ovarian cancer: a review. Gynecol Oncol. 2011;123(3):610–4.
Gmyrek L, Jonska-Gmyrek J, Sobiczewski P, Panek G, Bidzinski M. Evaluation of intraoperative and postoperative complications related to lymphadenectomy in ovarian cancer patients. Oncol Lett. 2011;2(3):537–41.
Sakuragi N, Yamada H, Oikawa M, Okuyama K, Fujino T, Sagawa T, Fujimoto S. Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0). Gynecol Oncol. 2000;79(2):251–5.
Petru E, Tamussino K, Lahousen M, Winter R, Pickel H, Haas J. Pelvic and paraaortic lymphocysts after radical surgery because of cervical and ovarian cancer. Am J Obstet Gynecol. 1989;161(4):937–41.
Powless CA, Aletti GD, Bakkum-Gamez JN, Cliby WA. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging. Gynecol Oncol. 2011;122(3):536–40.
Ayhan A, Gultekin M, Taskiran C, Celik NY, Usubutun A, Kucukali T, Yuce K. Lymphatic metastasis in epithelial ovarian carcinoma with respect to clinicopathological variables. Gynecol Oncol. 2005;97(2):400–4.